USA: Medication significant Cipla on Wednesday said it has released 'Qvir', a four-drug kit costing Rs 158 per kit to be used for the HIV/AIDS. The kit includes two pills packed together in one remove which symbolizes just one daily therapy, Cipla said in a declaration.
Commenting on the release Cipla Chair and Handling Home YK Hamied said: "While we are dedicated to creating medication cost-effective and available, we also effort to have more alternatives for HIV contaminated sufferers, which are effective, efficient, patient-friendly and simple to take".
As the pills are packed together in one remove, the affected person does not have to keep in mind which product he took, and cannot incorrectly take two of the same product, the organization said.
Studies of this mixture routine (one product having mixture of Tenofovir plus Emtricitabine and the other containing a variety of Atazanavir plus Ritonavirhave) have proven that it is efficient and well accepted by over 80 % of sufferers, it included.
Qvir kit is produced in Cipla's factory in Patalganga, the organization said.
Cipla is known for presenting HIV/AIDS therapy at a portion of the worldwide costs, but also for revolutionary the 3-in-1 blends.
Shares of Cipla on Wednesday resolved at Rs 348.95 on the BSE, down 0.29 % from their past near.
No comments:
Post a Comment